The modern view on etiology, pathogenesis and modes of treatment of hysteromyoma


Cite item

Full Text

Abstract

The article presents actual data concerning possible pathology and pathogenesis of hysteromyoma. The various views and theories related to origin of this disease are presented. The modern classifications of this pathology are expounded. The alternatives of conservative and operative treatment depending on age of patients, clinical manifestations of disease, presence of complaints and concern of preservation and realization of reproductive function. The approaches to treatment of given pathology from the position of endocrinology and organ-preserving and reconstructive surgery are exposed. The issues of surgical and hormonal therapy in female patients of reproductive and premenopause age. The operational approaches depending on size, type of growth, localization of myoma nodes and technical possibilities of hospital are described in details. The article enumerates innovative modes of treatment of hysteromyoma using ultrasound, high temperature, embolization of vessels supplying blood to myoma node.

About the authors

Lyudmila Mikhailovna Kondratovitch

The V.I. Kulakov research center of obstetrics, gynecology and perinatology of Minzdrav of Russia

Email: klm80sm@mail.ru
a postgraduate student in the Department of operative gynecology 117997, Moscow, Russia

References

  1. Адамян Л.В., Ткаченко Э.Р. Современные аспекты лечения миомы матки. Медицинская кафедра. 2003; 4 (8): 110-8.
  2. Азиев О.В., Бугеренко А.Е., Иванова Н.В. Использование задней кольпотомии при оперативной лапароскопии. Акушерство и гинекология. 1996; 5: 25-7.
  3. Eisinger S.H., Bonfiglio T., Fiscella K. et al. Twelve-month safety and efficacy of low-dose mifepristone for uterine myomas. J. Minim. Invasive Gynecol. 2005; 12: 227-33.
  4. Bourne Т.Н. Transvaginal color Doppler in gynecology. Ultrasound Obstet. Gynecol. 1991; 1(5): 359-73.
  5. Evans P. Georgetown university-providence hospital family practice residency program. Fam. Physicians. 2007; 75(10): 1503-8.
  6. Zhang Y., Hua K.Q. Patients' age, myoma size, myoma location, and interval between myomectomy and pregnancy may influence the pregnancy rate and live birth rate after myomectomy. J. Laparoendosc. Adv. Surg. Tech. A. 2014; 24(2): 95-9.
  7. Ланчинский В.И. Современные аспекты патогенеза, диагностики и хирургического лечения миомы матки: Дис.. д-ра мед. наук. М.; 2005.
  8. Sato K., Yuasa N., Fujita M., Fukushima Y. Clinical application of diffusion-weighted imaging for preoperative differentiation between uterine leiomyoma and leiomyosarcoma. Am. J. Obstet. Gynecol. 2013; Dec 21. doi: 10.1016/j.ajog.2013.12.028.
  9. Gurates B., Parmaksiz C., Kilic G. et al. Treatment of symptomatic uterine leiomyoma with letrozole. Reprod. Biomed. Online. 2008; 17: 569-74.
  10. Coddington C.C., Grow D.R., Ahmed M.S., Toner J.P., Cook E., Diamond M.P. Gonadotropin-releasing hormone agonist pretreatment did not decrease postoperative adhesion formation after abdominal myomectomy in a randomized control trial. Fertil. Steril. 2009; 91(5): 1909-13.
  11. Савельева Е.М., Азиев О.В. Современные представления о лапароскопических операциях повышенной сложности. В кн.: Лапароскопия и гистероскопия в гинекологии и акушерстве. М.: Пантори; 2002: 505-50.
  12. Курашвили Ю.Б., Сидорова И.С., Кузнецов С.Л. и др. Патогенетическая терапия при быстром росте миомы матки в репродуктивном возрасте. В кн.: Материалы III Российского форума "Мать и дитя". М.; 2001: 385-6.
  13. Ludwin A., Ludwin I., Pitynski K., Basta P., Basta A., Banas T. Transrectal ultrasound-guided hysteroscopic myomectomy of submucosal myomas with a varying degree of myometrial penetration. J. Minim. Invasive Gynecol. 2013; 20(5): 672-85.
  14. Varelas F.K., Papanicolaou A.N., Vavatsi-Christaki N. et al. The effect of anastrazole on symptomatic uterine leiomyoma. Obstet. Gynecol. 2007; 110: 643-9.
  15. Медведев М.В., Хохолин В.Л. Ультразвуковое исследование матки. В кн.: Митьков В.В., Медведев М.В., ред. Клиническое руководство по ультразвуковой диагностике. М.: Видар; 1997; т. 3: 76-119.
  16. Кулаков В.И., Адамян E.B., Мынбаев O.A. Оперативная гинекология. Хирургические энергии. М.: Антидот; 2000.
  17. Ellis H., Moran B., Thompson J. et al. Adhesion-related hospital readmissions after abdominal and pelvic surgery: a retrospective cohort study. Lancet. 1999; 353: 1476-80.
  18. Rein M.S. Advances in uterine leiomyoma research: the progesterone hypothesis. Environ. Health Perspect. 2000; 108 (Suppl. 5): 791-3.
  19. Spies J.B. Current evidence on uterine embolization for fibroids. Semin. Intervent. Radiol. 2013; 30(4): 340-6.
  20. Иванова Н.В. Консервативная миомэктомия эндоскопическими методами: Автореф. дисс.. канд. мед. наук. М.; 1998.
  21. Semih Mun, Ahmet Uysal, Ahmet Sejkin Onoglu, Fatma Uysal, Cuneyt Eftal Taner. The effects of hysteroscopic submucosal myoma. Resection on Number of Sanitary Pads. J. Clin. Anal. Med. doi: 10.4328/JCAM.1820/Published Online: 04.05.2013.
  22. Litta P., Conte L., De Marchi F., Saccardi C., Angioni S. Pregnancy outcome after hysteroscopic myomectomy. Gynecol. Endocrinol. 2013; Dec 5.
  23. Campo S. Hysteroscopy requirements and complications. Minerva Gynecol. 2007; 59(4): 451-7.
  24. Кулаков В.И., Селезнева Н.Д., Белоглазова С.Е. Руководство по оперативной гинекологии. М.: МИА; 2006: 227-81.

Copyright (c) 2014 Eco-Vector


 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies